Oramed Pharmaceuticals (ORMP) Depreciation and Depletion (2010 - 2026)
Oramed Pharmaceuticals (ORMP) posted Depreciation and Depletion of $30000.0 for Q1 2026, little changed on a QoQ basis from $30000.0 in Q4 2025, and little changed year-over-year from $30000.0 in Q1 2025.
Oramed Pharmaceuticals (ORMP) Depreciation and Depletion (2010 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Depreciation and Depletion history runs 17 years deep, the most recent figure standing at $30000.0 for Q1 2026.
- Quarterly Depreciation and Depletion changed 0.0% year-over-year to $30000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $121000.0 (down 27.54% YoY) and the FY2025 annual result came in at $121000.0, down 37.31% from the prior year.
- Depreciation and Depletion was $30000.0 for Q1 2026 at Oramed Pharmaceuticals, roughly flat from $30000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $56000.0 in Q1 2024 and bottomed at $11000.0 in Q1 2022.
- A 5-year average of $35176.5 and a median of $31000.0 in 2024 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2023 — Depreciation and Depletion surged 260.0% — and 2025, when it plunged 46.43%.
- Oramed Pharmaceuticals' Depreciation and Depletion stood at $17000.0 in 2022, then jumped by 211.76% to $53000.0 in 2023, then plunged by 41.51% to $31000.0 in 2024, then fell by 3.23% to $30000.0 in 2025, then changed by 0.0% to $30000.0 in 2026.
- Business Quant data shows ORMP's Depreciation and Depletion at $30000.0 in Q1 2026, $30000.0 in Q4 2025, and $31000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Sep 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Dec 31, 2023 | 53,000.00 |
| Dec 31, 2023 | 53,000.00 |